Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Total Debt (2016 - 2022)

Historic Total Debt for Fennec Pharmaceuticals (FENC) over the last 8 years, with Q3 2022 value amounting to $25.0 million.

  • Fennec Pharmaceuticals' Total Debt changed N/A to $25.0 million in Q3 2022 from the same period last year, while for Sep 2022 it was $25.0 million, marking a year-over-year change of. This contributed to the annual value of $167.0 million for FY2017, which is 50596060.61% up from last year.
  • Per Fennec Pharmaceuticals' latest filing, its Total Debt stood at $25.0 million for Q3 2022.
  • Fennec Pharmaceuticals' Total Debt's 5-year high stood at $25.0 million during Q3 2022, with a 5-year trough of $5.0 million in Q1 2022.